Skip to main content

Table 3 Total and Free Serum Isoflavones and Androgen Receptor CAG repeat

From: Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapy

Patient No. Total Genistein (μg/ml) Total Daidzein (μg/ml) Total Equol (μg/ml) Androgen Receptor CAG repeat
1 0.709 0.735 0.115 21
2 1.284 0.660 0.063 26
3 0.189 0.468 0.331 21
4 0.555 0.409 0.306 21
5 0.102 0.572 0.523 13
6 0.739 0.468 0.039 16
7 2.071 0.602 0.329 20
8 N/A N/A N/A 30
9 0.022 0.014 0.020 21
10 N/A N/A N/A 24
11 0.023 0.568 <0.001 16
12 0.186 0.063 0.061 16
13 <0.002 0.005 0.048 19
14 0.058 0.192 0.050 21
15 1.049 0.580 0.188 21
16 0.492 0.170 0.062 17
17 1.989 0.817 0.492 24
18 <0.002 0.021 0.119 19
19 N/A N/A N/A N/A
20 N/A N/A N/A N/A
Median 0.524 0.468 0.115 ---
  1. N/A, not assessed (adequate sample unable to be obtained)
  2. μg, microgram
  3. mL, milliliter
  4. MW, molecular weight
\